TNF‐alpha antagonists vs placebo
IBDQ at weeks 6 or 8 · people with active UC
TNF‐alpha antagonists leads to higher improved IBDQ at weeks 6 or 8 compared with placebo (high certainty).
2 findings from 1 review
- The impact of biological interventions for ulcerative colitis on health‐related quality of life 2015 · Cochrane Headline outcomes onlyRR 1.32 [1.19, 1.46]3 studies · 1495 participantsHigh
- The impact of biological interventions for ulcerative colitis on health‐related quality of life 2015 · Cochrane Headline outcomes onlyno estimate extracted4 studies · 1565 participantsModerate